Overview of Dr. Creelan
Office
12902 USF Magnolia Drive
Tampa, FL 33612
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2010 - 2013
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2007 - 2010- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2007
Certifications & Licensure
FL State Medical License 2009 - 2026
PA State Medical License 2007 - 2010- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC Start of enrollment: 2023 Jan 23
Roles: Contact
Publications & Presentations
PubMed
- 76 citationsSirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells.Imene Hamaidi, Lin Zhang, Nayoung Kim, Min-Hsuan Wang, Cristina Iclozan
Cell Metabolism. 2020-09-01 - 1536 citationsFirst-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung CancerDavid P. Carbone, Martin Reck, Luis Paz-Ares, Benjamin C. Creelan, Leora Horn
The New England Journal of Medicine. 2017-06-21 - 106 citationsContinuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.David M. Waterhouse, Edward B. Garon, Jason C. Chandler, Michael McCleod, Maen A. Hussein
Journal of Clinical Oncology. 2020-09-10
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
